Moderators
    • Internal Medicine
    • Medical Oncology
    • Breast Cancer
    • Basic Research
    • Clinical Research
    Physician-scientist at Dana Farber Cancer Institute studying residual disease in breast cancer.
    Physician-scientist at Dana Farber Cancer Institute studying residual disease in breast cancer.

    Sheheryar Kabraji BM BCh, is a medical oncologist specializing in the care of people with breast cancer. He runs an active laboratory-based research program aimed at understanding mechanisms of drug resistance leading to residual disease in breast cancer, with a focus on using patient-derived tissues and models. Dr. Kabraji completed his fellowship at Dana Farber/Partners Cancer Care Hematology/Oncology Fellowship Program and was a resident in Internal Medicine at Massachusetts General Hospital, both in Boston, MA. Dr Kabraji is the author of a textbook on Clinical Skills for Medical Students and has a special interest in aligning clinical skills, such as physical examination and patient-doctor communication, with evidence-based practice.

    • Radiation Oncology
    • Breast Cancer
    Dr. Spina is an Intern in the Department of Medicine at Mount Auburn Hospital where she will spend the year before joining the Department of Radiation Oncology at Columbia University to complete her residency training. She is currently a member of a multi-institutional collaboration working to develop a non-invasive test for breast cancer detection, assessment of cancer progression and response to treatment. Also interested in international health, she has volunteered in low-income countries, including Cambodia, to develop programs to improve access to breast cancer treatment for the poor. Dr. Spina completed her MD/PhD at Boston University and her doctoral research at the Wyss Institute for Biologically Inspired Engineering with with Jim Collins, PhD and Donald Ingber MD, PhD.
    MD Program at Boston University School of Medicine; Summer Fellowship at Dana-Farber Cancer Institute
    MD Program at Boston University School of Medicine; Summer Fellowship at Dana-Farber Cancer Institute
    Arthur is a second year medical student at Boston University School of Medicine with a strong interest in oncology research. At the Dana-Farber, Arthur is currently working to discover genetic markers in patients with Diffuse Large B-cell Lymphoma (DLBCL) via deep sequencing of patient samples. His project involves using knockout techniques such as the CRISPR/Cas9 system to help characterize candidate regulatory and tumor suppressor genes, including those involved in immune checkpoint dysregulation. Prior to medical school, and under the guidance of Dr. Frederick Alt from Harvard Medical School, Arthur investigated B-lymphocyte development with a focus on the DNA repair mechanisms and epigenetics of V(D)J recombination, as well as their implications on B-lymphocyte genomic stability. Arthur received his undergraduate degree in analytical chemistry and biochemistry from Boston University, where he received the Beckman Scholar Award for his research in natural product organic synthesis and drug discovery. His work focused on the total synthesis of DNA double strand break-inducing natural products and their derivatives. In his spare time, Arthur serves as a writer and lead editor for The Beat (see @ thebeatatbusm.com), a medical student-led online publication. In his downtime, he enjoys hiking.